The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each year.
Bayer wins FDA breakthrough therapy designation for NSCLC candidate – Pharmaceutical Technology
Share this article Bayer is now eligible to receive fast track benefits and added guidance from the agency for the drug’s development plan, as per